The ALTITUDE clinical science program is analyzing comprehensive data from the LATITUDE^® Patient Management system to provide insight into meaningful questions related to implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) therapy. The ALTITUDE program is managed in collaboration with an external physician panel of thought leaders who assist in identifying relevant clinical issues for analysis.

Boston Scientific has enrolled over 150,000 patients on the LATITUDE system since its introduction in 2006, making it the most rapidly adopted remote monitoring system for cardiac devices in the industry.¹ The database has had over 5 million transmissions making it a powerful source of data from a very large, non-selected patient population that is 20 times the enrollment of most clinical trials.

The LATITUDE system allows physicians to schedule remote follow-ups of implantable cardiac devices to monitor specific device information and patient heart health status. It can also detect clinical events between scheduled visits and send relevant data directly to physicians. This regular, remote in-home monitoring offers convenience and peace of mind for patients, and through the ALTITUDE program, a wealth of population information for physicians.

¹Data based on number of patients reported at 3 years post-launch. Data on file.

Safety Information